Matthew D. Marsden

This paper demonstrates that combining HIV-specific CAR T cells with rapamycin and latency reversing agents can reduce immune exhaustion and effectively target HIV-infected cells.

This study shows that rapamycin enhances CAR-T cell function and reduces HIV viral rebound and reservoir in HIV-infected humanized mice.